Gattefossé

Abstract The oral bioavailability of marketed ivermectin (IVR) tablets is 50% compared to an oral hydroalcoholic solution. In this study,...

Abstract Background/Objectives: The ABCG2 transporter actively effluxes anticancer drugs, reducing their efficacy and promoting multidrug resistance (MDR). Developing oral formulations...

Inertness Compritol® 888 ATO is inert Compritol® 888 ATO - glyceryl dibehenate - does not react with active pharmaceutical ingredients...

  Lipid excipients offer a unique combination of benefits Poor solubility, poor permeability, and pre-systemic elimination are factors that can...

Skin, a gate to drug delivery Many approaches have been developed to overcome the skin barrier properties, including vehicledrug interactions,...

Compritol® 888 ATO: one excipient benefits all, from formulator to end-user Compritol® 888 ATO With a drug release governed by...

Abstract The excipient, Capryol® 90, comprises 90 % monoesters of propylene glycol monocaprylate (C8). With a low hydrophilic lipophilic balance...

Abstract Cancer remains to be one of the most life-threatening diseases with high rates of mortality and morbidity. The major...

Abstract Lipid-based formulations (LBFs) play a crucial role in enhancing the oral bioavailability of poorly water-soluble drugs by leveraging lipid...

Abstract Background: Centaurium erythraea Rafn. (C. erythraea) is a medicinal plant traditionally used in European folk medicine for the treatment of...